World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
54
Citations
12479
World Ranking
3871
National Ranking
179

Best Publications

  • Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis

    Rami Moucari;Tarik Asselah;Dominique Cazals–Hatem;Hélène Voitot

  • Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C

    Michele Martinot-Peignoux;Patrick Marcellin;Michele Pouteau;Corinne Castelnau

  • Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients.

    Rami Moucari;Rami Moucari;Vincent Mackiewicz;Olivier Lada;Olivier Lada;Marie-Pierre Ripault;Marie-Pierre Ripault

  • Fibrosis and disease progression in hepatitis C

    Patrick Marcellin;Tarik Asselah;Nathalie Boyer

  • Recombinant human α‐interferon in patients with chronic non‐A, non‐B hepatitis: A multicenter randomized controlled trial from France

    Patrick Marcellin;Nathalie Boyer;Emile Giostra;Claude Degott

  • Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis.

    Ana-Carolina Cardoso;Rami Moucari;Claudio Figueiredo-Mendes;Marie-Pierre Ripault

  • The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

    Vincent Di Martino;Pierre Rufat;Nathalie Boyer;Philippe Renard

  • Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C

    Sarah Maylin;Sarah Maylin;Michelle Martinot–Peignoux;Michelle Martinot–Peignoux;Rami Moucari;Nathalie Boyer

  • Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers.

    Michelle Martinot-Peignoux;Nathalie Boyer;Magalie Colombat;Rahouda Akremi

  • Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up.

    Corinne Castelnau;Frédéric Le Gal;Marie-Pierre Ripault;Emmanuel Gordien

  • Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C

    Tarik Asselah;Ivan Bieche;Stéphanie Narguet;Audrey Sabbagh

  • Pathogenesis, diagnosis and management of hepatitis C

    Nathalie Boyer;Patrick Marcellin

  • Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives.

    Tarik Asselah;Nathalie Boyer;David Saadoun;Michele Martinot-Peignoux

  • Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B

    Vincent di Martino;Thierry Thevenot;Jean–François Colin;Nathalie Boyer

  • Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin.

    Michelle Martinot-Peignoux;Christiane Stern;Sarah Maylin;Marie-Pierre Ripault

  • High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study.

    Rami Moucari;Anneke Korevaar;Anneke Korevaar;Olivier Lada;Olivier Lada;Michelle Martinot-Peignoux;Michelle Martinot-Peignoux

  • Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.

    Michelle Martinot-Peignoux;Nathalie Boyer;Dominique Cazals-Hatem;Bach-Nga Pham

  • IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C

    Tarik Asselah;Simon De Muynck;Philippe Broët;Julien Masliah-Planchon;Julien Masliah-Planchon

  • Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C.

    Ana-Carolina Cardoso;Roberto J. Carvalho-Filho;Roberto J. Carvalho-Filho;Christiane Stern;Alexandrine Dipumpo

  • Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C

    Laure Elkrief;Pascale Chouinard;Noelle Bendersky;David Hajage

Frequent Co-Authors

Patrick Marcellin
Patrick Marcellin Université Paris Cité
Dominique Valla
Dominique Valla Université Paris Cité
Claude Degott
Claude Degott Beaujon Hospital
Jean-Pierre Benhamou
Jean-Pierre Benhamou Grenoble Alpes University
Tarik Asselah
Tarik Asselah Université Paris Cité
Michel Vidaud
Michel Vidaud Université Paris Cité
Fabrice Carrat
Fabrice Carrat Sorbonne University
Marie-Hélène Nicolas-Chanoine
Marie-Hélène Nicolas-Chanoine Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Nathalie Boyer